Company profile
Ludger Limited
Glycoprofiling Tools and Services | Ludger Ltd
Ludger Limited is a UK company with status active founded in 1999 based in South East England.
Latest accounts
Financial period: 1 Jan 2024 to 31 Dec 2024
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION
1 Jan 2023 to 31 Dec 2028
no public description
GlyHealth-COVID: A precision medicine test to identify ImmunoFrail patients at high risk of becoming severely ill or dying from COVID-19
1 Jul 2020 to 31 Mar 2021
This project is to accelerate the development of a proof-of-concept prototype of **GlyHealth-COVID** - a medical technology we are designing to identify '**immunofrail**' individuals who are at high risk of becoming severely ill or dying from COVID-19\. Initially, it was thought that only the elderly would get very sick and die from COVID-19 but around 25...
Hupela-PCOS-Filipina: A feasibility study for a lifestyle programme for women with polycystic ovary syndrome living in the Philippines
1 Apr 2020 to 30 Sep 2020
This is a project to help women living with polycystic ovary syndrome (PCOS) in the Philippines. PCOS results from a hormonal imbalance that can lead to infertility, disordered menstrual cycle, masculinisation and weight gain. Long-term complications include diabetes and increased risk of ovarian cancer. PCOS is the major cause of female infertility in th...
GlycanDx-MODY - a glycomics precision diagnostic assay for MODY diabetes
1 Feb 2017 to 31 Jan 2018
GlycanDx-MODY is a test to identify patients with HNF1A-type Maturity Onset Diabetes of the Young (MODY). This is a type of diabetes affecting up to 4% of diabetics (40K-160K cases in the UK) that can be treated with inexpensive oral drugs. Most MODY patients are misdiagnosed and prescribed insulin, which does not treat their disease, is inconvenient and ...